SmallCap Sentinel: Top Ranking Republican Presses for Stem Cell Funding as Public Companies Ponder the Future


IRVINE, Calif., Aug. 2, 2005 (PRIMEZONE) -- "Senate majority leader Bill Frist's unexpected support for the expansion of federal funding for embryonic stem cell research must be seen as an enormous positive for companies focused on research," stated SmallCap Sentinel analyst, D.R. Clark. "Not only could this mean federal funding for research projects but it appears to signal an erosion of resistance from within the Republican party."

"It will be interesting to see if Sen. Frist and President Bush 'square off' on this issue or if Frist is simply making the overt moves to save Bush from having to acquiesce on an issue on which he took a passionate stance," added Clark.

An informational report titled "Looking at the Political Impact on Stem Cell Research" has been made available free of charge via financial courier StockUpTicks.com at www.SmallCapSentinel.com

New Life Scientific (OTCBB:NWLF), which endeavors to blend Eastern European research and development with Western management, Genentech, Inc., Sepracor Inc., and Celgene Corporation will be discussed in the report.

Individuals may also register to receive free future reports at: http://stockupticks.com/register.html

Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect the results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project its capabilities, intent, resources, or experience.

All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid thirty-six hundred dollars for preparation and distribution of this report and other advertising services by Emerging Markets Consulting LLC. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.



            

Tags


Contact Data